WHO urges countries to commit to the Covid-19 vaccine? In a statement released on Thursday, June 18, the organization called on countries to mass produce it as soon as a formula has been validated. Of the 300 or so products tested, three are said to be undergoing human testing, according to WHO chief scientist Soumya Swaminathan.
The necessary support from countries
“If these trials prove successful, there could be a few hundred million doses of one or more vaccines by the end of the year,” she said. She even estimates that billions should be available in 2021. To achieve this, WHO relies on investments and support from countries to the COVAX device, created to develop global access to the Covid-19 vaccine. “We can only do this if the world comes together, if the countries come together and accept this mechanism,” explains the scientist.
Agreement to define priority people for vaccination
“So, we are proposing a framework that could be used to decide who should be given priority,” she adds. WHO is working on a global agreement to determine who will be the first to be vaccinated? Dr. Soumya Swaminathan talks about healthcare workers, the police, grocery workers but also people at risk: the elderly, people with hypertension, diabetes, or dementia. “People living in prisons, retirement homes, factories and urban slums where epidemics have been identified should also receive inoculation as a priority,” she added. In summary, three groups of people will be considered a priority: people on the front line facing the virus, the most vulnerable and those living in environments where transmission is high.
Guaranteed doses in the European Union?
To protect the global population of Covid-19, which has killed more than 450,000 people, will require a significant number of vaccines. The pharmaceutical industry estimates that two doses per person will be needed, more than 15 billion. The European Union has already managed to secure 300 million by signing an agreement on Saturday, June 13, with the pharmaceutical group AstraZeneca. All EU countries and other voluntary European countries will have access to the vaccine as soon as a formula is validated.
Hugues Louissaint is an entrepreneur and writer, living in the US for over a decade. He has launched successful products such the Marabou Coffee brand, which has been highly successful in Florida. He has also been a writer for more than 5 years focusing on science, technology, and health. He writes part-time for the Scientific Origin and provides valuable input on a wide range of subjects.